作者:John Unitt、Malbinder Fagura、Tim Phillips、Sarah King、Matthew Perry、Andrew Morley、Cathy MacDonald、Richard Weaver、Jadeen Christie、Simon Barber、Rukhsana Mohammed、Melanie Paul、Andrew Cook、Andrew Baxter
DOI:10.1016/j.bmcl.2011.03.049
日期:2011.5
The identification of two novel series of formyl peptide receptor 1 (FPR1) antagonists are reported, represented by methionine benzimidazole 6 and diamide 7. Both series specifically inhibited the binding of labelled fMLF to hrFPR1 and selectively antagonized FPR1 function in human neutrophils, making them useful in vitro validation tools for the target. (C) 2011 Elsevier Ltd. All rights reserved.